What is the recommended treatment and prophylaxis for Francisella tularensis infection?

Treatment and Prophylaxis of Francisella tularensis Infection

For tularemia treatment, use fluoroquinolones (ciprofloxacin or levofloxacin) or aminoglycosides (gentamicin) as first-line therapy for 10 days, with doxycycline reserved for 14-21 days in less severe cases. 1

First-Line Treatment Options

The CDC 2025 guidelines establish three equally effective first-line antimicrobial classes for treating tularemia in adults and children 1:

Fluoroquinolones

• Ciprofloxacin: 400 mg IV every 8 hours OR 750 mg orally every 12 hours for 10 days 1
  • For pregnant patients in third trimester: consider 500 mg every 8 hours 1
• Levofloxacin: 750 mg IV or orally every 24 hours for 10 days 1

Aminoglycosides

• Gentamicin: 6 mg/kg IV or IM every 24 hours (extended-interval dosing) for 10 days 1
  • Monitor drug levels and extend dosing interval beyond 24 hours if indicated 1
  • For pregnant patients, some experts recommend conventional dosing rather than extended-interval 1

Tetracyclines

• Doxycycline: 200 mg loading dose, then 100 mg every 12 hours IV or orally for 14-21 days 1
  • Pediatric dosing: 4.4 mg/kg loading (max 200 mg), then 2.2 mg/kg every 12 hours (max 100 mg) 1
  • Critical caveat: Doxycycline monotherapy should NOT be used for severe infection or when treatment is delayed >2 weeks 1

Alternative Treatment Options

When first-line agents are contraindicated or unavailable 1:

• Moxifloxacin: 400 mg IV or orally every 24 hours for 10 days 1
• Ofloxacin: 400 mg IV or orally every 12 hours for 10 days 1
• Amikacin: 15 mg/kg IV or IM every 24 hours for 10 days 1
• Tobramycin: 6 mg/kg IV or IM every 24 hours for 10 days 1

Special Population: Pregnant Patients

For pregnant women with severe tularemia, initiate treatment with an aminoglycoside (gentamicin) if possible. 1

• First-line options remain ciprofloxacin, levofloxacin, or gentamicin for 10 days 1
• Combination therapy (e.g., gentamicin plus ciprofloxacin) can be used for severe disease, though minimal evidence shows improved outcomes over monotherapy 1
• Doxycycline is listed but requires 14-21 days and should be avoided in severe cases 1
• Azithromycin has been used successfully in three pregnant women with glandular, ulceroglandular, and oropharyngeal tularemia when started at 6-20 weeks' gestation, with treatment durations of 4-6 weeks 1

Treatment Principles

Transition to Oral Therapy

• Patients initially treated with IV or IM antimicrobials can transition to oral regimens once they have defervesced and clinically improved 1
• Switching antimicrobial class is permissible if needed 1

Severe Infection Management

• For severe presentations, consider initial aminoglycoside therapy 1
• Combination therapy with two antimicrobial classes (e.g., gentamicin plus ciprofloxacin) is an option, though evidence for superiority is minimal 1

Post-Exposure Prophylaxis (PEP)

While the provided evidence focuses primarily on treatment, the CDC 2025 guidelines indicate that ciprofloxacin, levofloxacin, gentamicin, and doxycycline are recommended for post-exposure prophylaxis 1, 2. Azithromycin has been added as an alternative PEP option 1.

Third-Tier Options

When first-line and alternative agents are exhausted or contraindicated 1:

Streptomycin

• Relegated to third-tier due to limited U.S. availability and administration complexity 1
• Dosing: 1 g IV or IM twice daily for adults; 15 mg/kg IV or IM twice daily for children (max 2 g/day) for 10 days 1, 3
• Important note: IV use is off-label; only IM formulation is FDA-approved 3
• Requires clear documentation of clinical rationale for IV route 3

Other Third-Tier Agents

• Chloramphenicol: Downgraded from alternative to third-tier due to risk of aplastic anemia and neonatal gray syndrome 1
• Azithromycin: Third-tier for treatment (but alternative for PEP) due to strain-dependent efficacy 1
  • Type A strains are uniformly susceptible 1
  • Type B biovar II strains are naturally resistant with MICs >256 µg/mL 1

Critical Pitfalls to Avoid

1. Do not use doxycycline monotherapy for severe infection or delayed treatment (>2 weeks) 1
2. Avoid beta-lactams: F. tularensis is resistant to most beta-lactam antibiotics, with high failure rates even with ceftriaxone 4, 5
3. Ensure adequate treatment duration: Shorter courses (<14 days with tetracyclines) result in relapse rates of 25-45.5% 1
4. Consider surgical drainage: For suppurative lymph nodes or persistent infection despite appropriate antibiotics, surgical intervention may be necessary 5
5. Early treatment is crucial: Delayed treatment (>2-3 weeks after onset) is associated with higher failure rates and need for surgical management 5

FDA Approval Status

None of the first-line agents (ciprofloxacin, levofloxacin, gentamicin) are FDA-approved specifically for tularemia treatment 1. However, they have been used frequently off-label with extensive clinical experience 1. Only streptomycin, doxycycline, tetracycline, and minocycline carry FDA approval for tularemia 1. Large-scale use after a bioterrorism event would require FDA Emergency Use Authorization 1.